Cancer Interception: Susan Domcheck, Md

Cancer Interception: Susan Domcheck, MD

Stanford Cancer Institute Breakthroughs in Cancer: Susan Domchek, MD

Stanford Cancer Institute

Seminar Clips: PARP Inhibitors and BRRCA1/2 Cancers- Susan Domchek, MD | Stanford Cancer Institute

Stanford Cancer Institute

Strategies for cancer interception/prevention in individuals with hereditary cancer syndromes

What's New in Hereditary Cancer? Part 2 by Susan Domchek, MD

Dr. Susan Domchek, MD - Executive Director, Basser Center for BRCA, Abramson Cancer Center, Penn

Progress, Potential, and Possibilities

Susan M. Domchek, MD: The Importance of Genetic Testing

Vital Options International

Meet Potamkin Prize Awardee: Susan Domchek, M.D.

A Game-Changing Therapy for High-Risk Breast Cancers: An Interview with Susan M. Domchek, MD

Breast Cancer Research Foundation

Dr. Domchek Discusses Areas of Investigation in Breast Cancer

Dr. Domchek on the MEDIOLA Trial in Breast Cancer

Dr. Domchek on Results of the MEDIOLA Trial in BRCA-Mutated Metastatic Breast Cancer

Dr. #SusanDomchek MD - #ExecutiveDirector #PennMedicine #BasserCenter for #BRCA #Cancers

Progress, Potential, and Possibilities

Dr. Domchek Discusses Unanswered Questions from the MEDIOLA Trial

Susan M. Domchek, MD: PARP Inhibitor Clinical Trials Update at AACR 2012

Vital Options International

Ask Dr. Domchek: Ovarian Cancer Surveillance & More

Basser Center for BRCA

Ask Dr. Domchek: Breast Cancer Prevention in Young Women with BRCA Mutations

Basser Center for BRCA

Ask Dr. Domchek: Different Types of Breast Cancers

Basser Center for BRCA

Ask Dr. Domchek: Follow Up Guidelines for BRCA-Related Breast Cancer Recurrence

Basser Center for BRCA

Ask Dr. Domchek: Lifestyle Interventions to Reduce Cancer Risk

Basser Center for BRCA